In this episode of the Health Policy Podcast, Prof. Christopher Snyder discusses the FDA's exploration of drug repurposing and the economic incentives surrounding it. Snyder explains how generic drugs often miss opportunities for secondary uses due to a lack of financial motivation for manufacturers after patent expiration. He also highlights the work of the Market Shaping Accelerator, a collaborative initiative aimed at enhancing innovation in public health and addressing market failures.